TSHA

Taysha Gene Therapies, Inc.

6.21

-0.73-10.52%

Pre Market: 6.35 +0.14 +2.25%04:39 06/26 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE6.83/6.94

TODAY RANGE6.06-6.83

VOL80

MARKET CAP1.78B

52 WEEK RANGE2.250-7.30

AVG VOL (3M)2.77M

% TURNOVER4.10%

TURNOVER0

P/E (TTM)-16.4984

% RANGE11.02%

EPS(TTM)-0.3764

P/E(FORWARD)-13.2128

P/B8.42

BVPS0.7378

DIVIDEND--

P/S181.05

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP1.59B

SHARES OUTSTANDING287.36M

NEXT EARNINGS08/10-08/14

FREE FLOAT256.76M

LOT SIZE1

EX-DATE--

Feeds

News

Press Releases

Financial Reports

Profile

Same Industry

Name/Symbol

Change%

Price

TSHA

Regeneron Pharmaceuticals

REGN

-0.53%

620.14

GridAI Tech

GRDX

-2.06%

4.760

BNTX

United Therapeutics Corp.

UTHR

-2.70%

536.59

Vertex Pharmaceuticals Inc

VRTX

+0.62%

478.14

SIGA

Moderna

MRNA

+3.50%

63.96

CRL

Medpace Holdings

MEDP

+8.30%

512.79

Talphera Inc

TLPH

+0.95%

1.060

ICON plc

ICLR

+1.76%

160.96

CBPO

Iqvia Hldgs Inc

IQV

+8.37%

185.62

MOLN

Arcturus Therape

ARCT

+2.31%

7.53

Gilead Sciences Inc

GILD

+0.90%

124.87

PRAH

Incyte Corp

INCY

-0.86%

107.53

Aptevo Therapeutics Inc

APVO

-2.71%

4.670

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.